Get started
Work

In silico evaluation of the 12-gene molecular score (EndoPredict) and the recurrence score (Oncotype DX) as predictors of response to neo-adjuvant chemotherapy in estrogen receptor positive (ER+), HER2 negative (HER2-) breast cancer.

Year: 2018
Type: conference-abstract
DOI: 10.1200/jco.2018.36.15_suppl.539
Authors: Hatem Hussein Soliman, Mark E. Robson, Susanne Wagner, Darl D Flake, Lee Steven Schwartzberg, Priyanka Sharma, Anthony Martin Magliocco, Ralf Kronenwett, Johnathan M. Lancaster, Jerry S Lanchbury, Alexander Gutin, William John Gradishar
Institutions: Moffitt Cancer Center, Memorial Sloan Kettering Cancer Center, Myriad Genetics, University of Tennessee Health Science Center, West Cancer Center, University of Kansas Medical Center, Fed­er­al Of­fice of Ad­min­is­tra­tion, Northwestern University
Language: English
Subfield: Cancer Research
Open Access status: closed
OpenAlex ID: W2805535494
Cites:
Cited by: 1
Related to: 10